Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy

J Am Coll Cardiol. 2011 Aug 23;58(9):988-9. doi: 10.1016/j.jacc.2011.05.025.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Adult
  • Aged
  • Anthracyclines / adverse effects*
  • Atorvastatin
  • Cardiomyopathies / blood
  • Cardiomyopathies / chemically induced*
  • Cardiomyopathies / prevention & control*
  • Cardiotonic Agents / therapeutic use*
  • Female
  • Follow-Up Studies
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Pyrroles / therapeutic use*
  • Treatment Outcome

Substances

  • Anthracyclines
  • Cardiotonic Agents
  • Heptanoic Acids
  • Pyrroles
  • Atorvastatin